Loading viewer...
investor_presentation
Format: PDF investor_presentation
Clinical trial results presentation for ORMD-0801, an oral insulin capsule for Type 2 Diabetes treatment. Study evaluated safety, efficacy, and pharmacodynamic effects on glucose levels in patients inadequately controlled with diet and metformin. Primary outcomes included nighttime glucose monitoring and hypoglycemia incidence assessment.
investor_presentation
35 Pages
investor_presentation
27 Pages
Dow Chemical Company